Home › Grants › United States › NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commerciali

NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)

The Small Business Innovation Research (SBIR) Program is an important National Institutes of Health (NIH) funding mechanism used to develop innovative solutions that address public health challenges.

Grant (non-repayable) Intake closed; program continues (check for next intake)

Funder

National Institutes of Health
Funder profile and all of its programs

Amount

Award amounts are not published in the listing; see the official page.

Where

United States (federal)

Eligibility

Open to businesses and self-employed people. No cost sharing is required. Recurring: posted in 3 different years; this cycle has closed, watch for the next one.

Sectors

Business and entrepreneurship, Health and life sciences, Research and science, Startups and new ventures, Technology, software and R&D, Youth

Deadline

Varies: check the official page for current dates

Source

Grants.gov XML extract (RFA-HL-26-015)

Last checked

2 November 2026

Funder contacts

Public organizational contacts on file Unlock full profile / Sign up

Official page ↗

From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.

Related grant lists

Business and entrepreneurship Health and life sciences Research and science Businesses and entrepreneurs United States United States (national) Federal agency

Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.